Plant-Derived Bioactive Compounds in Chronic Obstructive Pulmonary Disease: Targeting Oxidative Stress and Inflammatory Signaling
Open Access
- 12 November 2026
- journal article
- review article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (11) , 1206
Abstract
Chronic obstructive pulmonary disease (COPD) is characterised by persistent airflow limitation arising from chronic inflammation, oxidative stress, mucus hypersecretion, protease–antiprotease imbalance, airway remodelling, and emphysematous destruction. This review evaluates plant-derived bioactive compounds with reported activity against molecular processes implicated in COPD. Resveratrol, kaempferol, quercetin, fisetin, epigallocatechin gallate, gallic acid, ursolic acid, hesperidin, apigenin, and luteolin are examined with emphasis on Nrf2, NF-κB, MAPKs, PI3K/Akt, SIRT1, TLR4, and NLRP3 signalling. In selected cellular and animal models, these compounds have been reported to reduce oxidative stress, inflammatory mediator release, mucus production, metalloproteinase activity, and tissue injury. However, these experimental findings do not establish therapeutic efficacy in patients with COPD. Some also affect autophagy, corticosteroid sensitivity, and pathways associated with cellular senescence. Overall, the evidence is derived mainly from cultured cells and animal models, with limited clinical data. Poor oral bioavailability, rapid metabolism, uncertain pulmonary exposure, formulation variability, dose standardisation, and potential drug interactions remain major translational limitations. Future studies should define pharmacokinetics, lung tissue exposure, optimal formulations, safety, and interactions with standard COPD therapies, followed by adequately powered clinical trials assessing exacerbations, lung function, symptoms, exercise capacity, quality of life, and treatment-related adverse effects in well-defined COPD populations.Keywords
This publication has 178 references indexed in Scilit:
- Letter From the Japanese Respiratory SocietyRespirology, 2025
- An update on the potential mechanism of gallic acid as an antibacterial and anticancer agentFood Science & Nutrition, 2023
- Resveratrol regulates inflammation and improves oxidative stress via Nrf2 signaling pathway: Therapeutic and biotechnological prospectsPhytotherapy Research, 2023
- Kaempferol exerts a neuroprotective effect to reduce neuropathic pain throughTLR4/NF‐ĸBsignaling pathwayPhytotherapy Research, 2022
- Gallic acid protects against the COPD-linked lung inflammation and emphysema in miceInflammation Research, 2020
- Resveratrol: A miraculous natural compound for diseases treatmentFood Science & Nutrition, 2018
- Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary diseaseCochrane Database of Systematic Reviews, 2017
- Antioxidant Properties of Quercetin2011
- The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD)†Hepatology, 2008
- Anti-inflammatory mechanisms of apigenin: inhibition of cyclooxygenase-2 expression, adhesion of monocytes to human umbilical vein endothelial cells, and expression of cellular adhesion moleculesArchives of Pharmacal Research, 2007